Meropenem Sulbactam Injection, marketed as Flaxsat-S Injection, combines meropenem, a potent antibiotic, with sulbactam, a β-lactamase inhibitor. This dual action effectively treats severe infections caused by multidrug-resistant bacteria, including those resistant to other antibiotics. By inhibiting bacterial cell wall synthesis and protecting meropenem from degradation, this injection is crucial in combating complex infections like intra-abdominal infections and pneumonia. Careful administration and monitoring ensure optimal therapeutic outcomes while managing potential side effects.Available in PCD Franchise for injectable range and third party manufacturing.